Clinical Trial Update: Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ranibizumab to bevacizumab on macular perfusion in diabetic macular edema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy
• Macular Ischemia

Drugs mentioned

• Bevacizumab (bevacizumab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Cairo University | Conditions: Diabetic Macular Edema, Macular Ischemia | Phase 4 | Status: TERMINATED